STEPHANIE RIVERA: Open Payments
NPI 1053611343 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 34 payments from 13 companies in 2025. Trend: 2023 $539 · 2024 $601 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $216 |
| Galderma Laboratories, L.P. | 1 | $111 |
| GENZYME CORPORATION | 2 | $83 |
| Janssen Biotech, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $40 |
| Kerecis Limited | 1 | $39 |
| ABBVIE INC. | 2 | $37 |
| UCB, Inc. | 1 | $33 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $27 |
| Organogenesis Inc. | 1 | $25 |
Products named: COSENTYX, NEMLUVIO, DUPIXENT, TREMFYA, OTEZLA, Kerecis SurgiClose, Bimzelx, VIA MATRIX.
Industry payments across FL — which companies pay providers there.
